Exhaustion of the Frank-Starling mechanism in conscious dogs with heart failure induced by chronic coronary microembolization

Life Sciences
Robert M GillWeiqun Shen


The role of the Frank-Starling mechanism in the regulation of cardiac systolic function in the ischemic failing heart was examined in conscious dogs. Left ventricular (LV) dimension, pressure and systolic function were assessed using surgically implanted instrumentations and non-invasive echocardiogram. Heart failure was induced by daily intra-coronary injections of microspheres for 3-4 weeks via implanted coronary catheters. Chronic coronary embolization resulted in a progressive dilation of the left ventricle (12+/-3%), increase in LV end-diastolic pressure (118+/-19%), depression of LV dP/dt(max) (-19+/-4%), fractional shortening (-36+/-7%), and cardiac work (-60+/-9%), and development of heart failure, while the LV contractile response to dobutamine was depressed. A brief inferior vena caval occlusion in dogs with heart failure decreased LV preload to match the levels attained in their control state and caused a further reduction of LV dP/dt(max), fractional shortening, stroke work and cardiac work. Moreover, in response to acute volume loading, the change in the LV end-diastolic dimension-pressure (DeltaLVEDD-DeltaLVEDP) curve in the failing heart became steeper and shifted significantly to the left, while the increases in...Continue Reading


Sep 1, 1989·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·N B SchillerI Schnittger
Jul 22, 1982·The New England Journal of Medicine·M R BristowE B Stinson
May 1, 1994·Circulation Research·R H SchwingerE Erdmann
Aug 1, 1996·Clinical and Experimental Pharmacology & Physiology·D E VatnerS F Vatner
Jun 6, 1998·Cardiovascular Research·J WeilH Scholz
May 17, 2005·Cellular Signalling·Thierry MétayéJean-Louis Kraimps


Nov 4, 2006·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Isaac GeorgeJie Wang
Jul 24, 2010·Canadian Journal of Physiology and Pharmacology·Leonardo dos SantosPaulo J F Tucci
Oct 27, 2015·European Heart Journal·Arnold M Katz, Ellis L Rolett
Jun 24, 2011·International Journal of Cardiology·David H MacIver, Mark J Dayer
Apr 10, 2012·International Journal of Cardiology·David H MacIverAndrew J I Harrison
Jul 19, 2013·Biochimica Et Biophysica Acta·Vasco SequeiraJolanda van der Velden
Oct 19, 2013·Experimental and Therapeutic Medicine·Yupeng BaiHong Jiang
May 29, 2020·Circulation Journal : Official Journal of the Japanese Circulation Society·Shunsuke SaitoYoshiki Sawa
Aug 1, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Robert M GillWeiqun Shen
Sep 14, 2017·British Journal of Clinical Pharmacology·Ahmed Al-NaherMunir Pirmohamed
Feb 27, 2017·Journal of Applied Physiology·Eva RomitoFrancis G Spinale
Apr 11, 2018·The American Journal of Emergency Medicine·Metin ÇağdaşTufan Çınar

Related Concepts

Related Feeds


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.